Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Pharmaceutical Research|March 24, 2006
Use of in vitro critical inhibitory concentration, a novel approach to predict in vivo synergistic bactericidal effect of combined amikacin and piperacillin against Pseudomonas aeruginosa in a systemic rat infection modelEli Chan, Shufeng Zhou, Sahasranaman Srikumar, et al.
Pharmaceutical Research|April 20, 2005
Significant intestinal excretion, one source of variability in pharmacokinetics of COL-3, a chemically modified tetracyclineJing Li, Shufeng Zhou, Hung Huynh, et al.
Current Pharmaceutical Design|March 10, 2011
ADME properties of herbal medicines in humans: evidence, challenges and strategiesShu-Ming He, Eli Chan, Shu-Feng Zhou
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 9, 2011
Loading 3-deazaneplanocin A into pegylated unilamellar liposomes by forming transient phenylboronic acid-drug complex and its pharmacokinetic features in Sprague-Dawley ratsFeng Sun, Jian Li, Qiang Yu, et al.
Therapeutics and Clinical Risk Management|March 25, 2008
Clinical outcomes and management of mechanism-based inhibition of cytochrome P450 3A4Shufeng Zhou, Eli Chan, Xiaotian Li, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 21, 2007
Is a standard fixed dose of mycophenolate mofetil ideal for all patients?Wai-Ping Yau, Anantharaman Vathsala, Huei-Xin Lou, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 29, 2004
Simple reversed-phase ion-pair liquid chromatography assay for the simultaneous determination of mycophenolic acid and its glucuronide metabolite in human plasma and urineWai-Ping Yau, Anantharaman Vathsala, Huei-Xin Lou, et al.
International Journal of Oncology|July 31, 2003
Inhibition of ErbB-2 and ErbB-3 expression by quercetin prevents transforming growth factor alpha (TGF-alpha)- and epidermal growth factor (EGF)-induced human PC-3 prostate cancer cell proliferationHung Huynh, Thi Thanh Tuyen Nguyen, Eli Chan, et al.
Pharmaceutical Research|August 9, 2005
Alteration of the pharmacokinetics of COL-3, a matrix metalloproteinase inhibitor, due to acute gastrointestinal toxicity of doxorubicinJing Li, Shufeng Zhou, Hung Huynh, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 4, 2011
Quantification of 3-deazaneplanocin A, a novel epigenetic anticancer agent, in rat biosamples by hydrophilic interaction liquid chromatography-tandem mass spectrometric detectionFeng Sun, Jasmine Chiat-Ling Ong, Qiang Yu, et al.
Pageof 7